| Lipitor |
All Financial Data in US $ (mln) |
| Word Search (Top 10 - by date) |
Celera Publishes Review Article on the KIF6 Gene Variant as a Predictor of Risk of Coronary Heart Disease (CHD) and Reduction in Coronary Events from Statin Therapy
Celera
(August 18, 2010)
|
Pfizer Reports Second-Quarter 2010 Results
Pfizer
(August 03, 2010)
|
Financial Results of Astellas for the First Three Months of FY2010
Astellas Pharma
(August 02, 2010)
|
Abbott's Progress Study of Kaletra and Isentress Compared With a Standard HIV Regimen Meets The Pre-Specified Primary Efficacy Endpoint
Abbott Laboratories
(July 19, 2010)
|
Caduet Reduces 10-year Calculated Risk of Coronary Heart Disease, Fatal Cardiovascular Disease
Pfizer
(June 21, 2010)
|
Ranbaxy Launches Generic Atorvastatin, 'Lipogen', a Cholesterol-reducing Medication in South Africa
Ranbaxy Laboratories
(June 08, 2010)
|
Celera Announces CE Mark for KIF6 Test
Celera
(June 07, 2010)
|
Ranbaxy Launches Atorvastatin, Cholesterol-reducing Medication Into the Canadian Healthcare System
Ranbaxy Laboratories
(May 21, 2010)
|
Teva Announces Launch and Shipment of Generic Lipitor® Tablets in Canada
Teva Pharmaceutical Industries
(May 19, 2010)
|
Watson Launches Generic Version of LIPITOR® in Canada
Watson Pharmaceuticals
(May 19, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
| Summary Product Name Information |
|
|
| Product Sales Summary 2007/08 |
|
Annual Sales WW - Sales
|
Growth per Year (%)
|
|
Rank1 |
Generic Name
|
Therapeutic Subcategory
|
2007 |
2008
|
2008 |
| Lipitor2 |
|
|
|
13,533 |
13,353 |
|
-1% |
|
|
Note: Shaded Cells3 |
|
|
More Product Information for EvaluatePharma® subscribersSubscribers see:
- Sales (historic and forecast to 2016 where available) listed by the reporting company or companies, including royalty, license and JV revenue where applicable
- Details of all events impacting the product
- Detailed product information, including sales forecasts listed by the reporting company or companies, indications (approved and in trial)
|
Register to access more FREE content:
- 2009 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
|
|
|
|